Project: A cost-effective and broadly applicable mimetope based diagnostic platform for high-impact pandemics
| Acronym | TESTOMETIC (Reference Number: 114855) |
| Duration | 01/05/2021 - 01/11/2023 |
| Project Topic | TESTOMETIC will deliver a mimetope-based Point of Care (PoC) diagnostic test that can identify and measure antibodies reacting with various SARS-CoV-2 epitopes. TESTOMETIC will implement a next generation and widely applicable PoC platform that uses magnetic lateral flow immunoassay (LFA) for more sensitive quantitation. The PoC test will be a first demonstrator product of the platform for infectious diseases. By the end of the project, the test will be ready for CE-IVD certification. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 14 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Aegirbio AB | Coordinator | Sweden |
| 2 | Lionex GmbH | Partner | Germany |